fulltext.study @t Gmail

Competitive bioreactor hens on the horizon

Paper ID Volume ID Publish Year Pages File Format Full-Text
37725 45400 2006 3 PDF Available
Title
Competitive bioreactor hens on the horizon
Abstract

The hen has long held promise as a low-cost, high-yield bioreactor for the production of human biopharmaceuticals in egg whites using genetic engineering. Two separate reports have recently appeared indicating the production of substantial levels of human monoclonal and single chain antibodies (>3 mg and >150mg, respectively) in eggs of transgenic hens. These promising findings indicate that the hen is close to becoming a competitive manufacturing platform for the production of human biopharmaceuticals.

First Page Preview
Competitive bioreactor hens on the horizon
Publisher
Database: Elsevier - ScienceDirect
Journal: - Volume 24, Issue 3, March 2006, Pages 99–101
Authors
,
Subjects
Physical Sciences and Engineering Chemical Engineering Bioengineering